Can you walk us through what's out there in the industry and how sites are really engaging with what's available to them today?

Well, I'll tell you what we're seeing, Jimmy, is that CROs and sponsors are obviously embracing the idea that there's a need for technology, not just in study feasibility, but in all aspects of the clinical trial landscape.

And so because this is our focus, really the study feasibility is our focus, we are seeing that sponsors and CROs are starting to develop their own product.

Perhaps they're licensing out some products that are out there.

And obviously, the sites seem to be engaged and eager to use this technology because historically, this whole process has been a disruption to their day.

And, and we'll talk about that in a little bit.

I want to get Ryan's thoughts on this here.

For those listeners that maybe haven't seen something like this in action, can you, Cathy, maybe start us off here and break down how this technology works from the point in which a study opportunity comes in to when a site might make some sort of decision on it? Maybe the sort of the, the first step of how this would work.